FERRING Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FERRING, and when can generic versions of FERRING drugs launch?
FERRING has seventeen approved drugs.
There are twenty US patents protecting FERRING drugs.
There are two hundred and seventy-seven patent family members on FERRING drugs in forty countries and twenty-two supplementary protection certificates in ten countries.
Summary for FERRING
International Patents: | 277 |
US Patents: | 20 |
Tradenames: | 17 |
Ingredients: | 8 |
NDAs: | 17 |
Patent Litigation for FERRING: | See patent lawsuits for FERRING |
Drugs and US Patents for FERRING
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | 10,729,739 | ⤷ Sign Up | ⤷ Sign Up | ||||
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | 9,579,359 | ⤷ Sign Up | ⤷ Sign Up | ||||
Ferring Pharms Inc | DDAVP | desmopressin acetate | INJECTABLE;INJECTION | 018938-001 | Mar 30, 1984 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Ferring | LUTREPULSE KIT | gonadorelin acetate | INJECTABLE;INJECTION | 019687-002 | Oct 10, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Ferring Pharms Inc | PREPOPIK | citric acid; magnesium oxide; sodium picosulfate | FOR SOLUTION;ORAL | 202535-001 | Jul 16, 2012 | DISCN | Yes | No | 8,450,338 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FERRING
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ferring Pharms Inc | DDAVP | desmopressin acetate | SOLUTION;NASAL | 017922-001 | Approved Prior to Jan 1, 1982 | 5,763,407 | ⤷ Sign Up |
Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | 9,220,747 | ⤷ Sign Up |
Ferring Pharms Inc | DDAVP | desmopressin acetate | TABLET;ORAL | 019955-001 | Sep 6, 1995 | 5,763,407 | ⤷ Sign Up |
Ferring Pharms Inc | DDAVP (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 017922-003 | Aug 7, 1996 | 5,674,850 | ⤷ Sign Up |
Ferring Pharms Inc | DDAVP | desmopressin acetate | SOLUTION;NASAL | 017922-001 | Approved Prior to Jan 1, 1982 | 3,497,491 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for FERRING drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and 12 g | ➤ Subscribe | 2014-05-21 |
➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and12 g | ➤ Subscribe | 2019-02-11 |
International Patents for FERRING Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Eurasian Patent Organization | 200901075 | ⤷ Sign Up |
Eurasian Patent Organization | 200901074 | ⤷ Sign Up |
Canada | 2702152 | ⤷ Sign Up |
Japan | 5507467 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2009047633 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for FERRING Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2782584 | 301153 | Netherlands | ⤷ Sign Up | PRODUCT NAME: COMPOSITION CONTAINING BOTH ESTRADIOL (17SS-ESTRADIOL), OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF (INCLUDING IN HEMIHYDRATE FORM), AND PROGESTERONE; NATIONAL REGISTRATION NO/DATE: RVG 125821 20210611; FIRST REGISTRATION: BE BE582231 20210406 |
1003774 | SPC/GB09/028 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DEGARELIX OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT SUCH AS THE ACETATE; REGISTERED: UK EU/1/08/504/001 20090217; UK EU/1/08/504/002 20090217 |
1003774 | 91585 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: DEGARELIX, EVENTUELLEMENT UN SEL PHARMACEUTIQUEMENT ACCEPTABE, TEL QUE L'ACETATE (FIRMAGON); REG. DATE: 20090217 |
2712622 | PA2017001,C2712622 | Lithuania | ⤷ Sign Up | PRODUCT NAME: DESMOPRESINAS ARBA JO ACETATO DRUSKA; REGISTRATION NO/DATE: BE497271, 2016-05-04; LT1-16/3940/001-LT/1 6/3940/008 |
1003774 | PA2009005 | Lithuania | ⤷ Sign Up | PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.